Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Antibody</td><td class="align_center">Cat. no.</td><td class="align_center">Company</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">TLR-4</td><td class="align_center">AB22048</td><td class="align_center">Abcam</td></tr><tr><td class="align_left">TRAF-3</td><td class="align_center">SC-6933</td><td class="align_center">Santa Cruz</td></tr><tr><td class="align_left">NF-<i>κ</i>b p65</td><td class="align_center">8242</td><td class="align_center">Cell Signaling Technology</td></tr><tr><td class="align_left">P-p65</td><td class="align_center">3033</td><td class="align_center">Cell Signaling Technology</td></tr><tr><td class="align_left"><i>β</i>-actin (42KD)</td><td class="align_center">4970</td><td class="align_center">Cell Signaling Technology</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease 